These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21476871)

  • 1. Synthesis of recombinant high density lipoprotein with apolipoprotein A-I and apolipoprotein A-V.
    Zhang X; Chen B
    Biol Chem; 2011 May; 392(5):423-9. PubMed ID: 21476871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect in vitro of apolipoprotein A-V on the structure and functions of recombinant high density lipoprotein.
    Zhang X; Wang J; Chen B
    Biochem Biophys Res Commun; 2010 Oct; 401(3):473-9. PubMed ID: 20869952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of different proportions of apolipoprotein A-I cysteine mutants and apolipoprotein A-V on recombinant high-density lipoproteins
    Yan Y; Lu S; Jia S; Dong Q; Wang L; Wang Y
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31023964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1.
    Shu X; Nelbach L; Weinstein MM; Burgess BL; Beckstead JA; Young SG; Ryan RO; Forte TM
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2504-9. PubMed ID: 20966404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ApoA-I mutants V156K and R173C promote anti-inflammatory function and antioxidant activities.
    Cho KH; Park SH; Han JM; Kim HC; Choi YK; Choi I
    Eur J Clin Invest; 2006 Dec; 36(12):875-82. PubMed ID: 17087782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.
    Goldberg IJ; Scheraldi CA; Yacoub LK; Saxena U; Bisgaier CL
    J Biol Chem; 1990 Mar; 265(8):4266-72. PubMed ID: 2307668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A zebrafish model for the rapid evaluation of pro-oxidative and inflammatory death by lipopolysaccharide, oxidized low-density lipoproteins, and glycated high-density lipoproteins.
    Park KH; Cho KH
    Fish Shellfish Immunol; 2011 Dec; 31(6):904-10. PubMed ID: 21906681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the apoA-IV-2 isoprotein.
    Rader DJ; Schäfer J; Lohse P; Verges B; Kindt M; Zech LA; Steinmetz A; Brewer HB
    J Clin Invest; 1993 Aug; 92(2):1009-17. PubMed ID: 8349786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion.
    VerHague MA; Cheng D; Weinberg RB; Shelness GS
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2501-8. PubMed ID: 24030551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene.
    Pérez-Méndez O; Duhal N; Lacroix B; Bonte JP; Fruchart JC; Luc G
    Clin Chim Acta; 2006 Jun; 368(1-2):149-54. PubMed ID: 16487502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoproteins regulate the kinetics of endothelial lipase-mediated hydrolysis of phospholipids in reconstituted high-density lipoproteins.
    Caiazza D; Jahangiri A; Rader DJ; Marchadier D; Rye KA
    Biochemistry; 2004 Sep; 43(37):11898-905. PubMed ID: 15362876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants.
    Jonas A; von Eckardstein A; Kézdy KE; Steinmetz A; Assmann G
    J Lipid Res; 1991 Jan; 32(1):97-106. PubMed ID: 1901346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of apolipoproteins on the structure and function of spheroidal, reconstituted high density lipoproteins.
    Rye KA; Barter PJ
    J Biol Chem; 1994 Apr; 269(14):10298-303. PubMed ID: 8144610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A point mutant of apolipoprotein A-I, V156K, exhibited potent anti-oxidant and anti-atherosclerotic activity in hypercholesterolemic C57BL/6 mice.
    Cho KH; Park SH; Han JM; Kim HC; Chung YJ; Choi I; Kim JR
    Exp Mol Med; 2007 Apr; 39(2):160-9. PubMed ID: 17464177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl).
    Hadfield KA; Pattison DI; Brown BE; Hou L; Rye KA; Davies MJ; Hawkins CL
    Biochem J; 2013 Jan; 449(2):531-42. PubMed ID: 23088652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer.
    Calabresi L; Canavesi M; Bernini F; Franceschini G
    Biochemistry; 1999 Dec; 38(49):16307-14. PubMed ID: 10587455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation.
    Rye KA; Wee K; Curtiss LK; Bonnet DJ; Barter PJ
    J Biol Chem; 2003 Jun; 278(25):22530-6. PubMed ID: 12690114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.